Page last updated: 2024-10-27

flurbiprofen and Experimental Hepatoma

flurbiprofen has been researched along with Experimental Hepatoma in 2 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Menzel-Soglowek, S1
Geisslinger, G1
Brune, K1
Cyran, JA1
Lysz, TW1
Lea, MA1

Other Studies

2 other studies available for flurbiprofen and Experimental Hepatoma

ArticleYear
Metabolic chiral inversion of 2-arylpropionates in different tumor cell lines.
    Agents and actions. Supplements, 1993, Volume: 44

    Topics: Animals; Carcinoma, Hepatocellular; Cell Count; Culture Media; Flurbiprofen; Humans; Ibuprofen; Keto

1993
Influence of inhibitors of eicosanoid metabolism on proliferation of rat hepatoma cells and on tumor-host interaction.
    Prostaglandins, leukotrienes, and essential fatty acids, 1990, Volume: 39, Issue:4

    Topics: Acrylates; Animals; Arachidonic Acid; Arachidonic Acids; Bridged Bicyclo Compounds, Heterocyclic; Ce

1990